Dr. Dritschilo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-3320- Is this information wrong?
Education & Training
- Tufts Medical CenterResidency, Radiation Oncology, 1977 - 1977
- Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1974 - 1977
- University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1973 - 1974
- Rutgers New Jersey Medical SchoolClass of 1973
Certifications & Licensure
- MD State Medical License 1980 - 2024
- DC State Medical License 1979 - 2024
- VA State Medical License 1997 - 2018
- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies Start of enrollment: 2001 Mar 01
Publications & Presentations
PubMed
- 1 citationsRadiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition.Satish Kumar R Noonepalle, Scott Grindrod, Nima Aghdam, Xintang Li, Maria Gracia-Hernandez, Christian Zevallos-Delgado, Mira Jung, Alejandro Villagra, Anatoly Dritschilo> ;Molecular Cancer Therapeutics. 2023 Dec 1
- Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers.Amrita K Cheema, Yaoxiang Li, Mary Ventimiglia, Keith Kowalczyk, Ryan Hankins, Gaurav Bandi, Einsley-Marie Janowski, Scott Grindrod, Alejandro Villagra, Anatoly Dritsc...> ;Clinical Cancer Research. 2023 Mar 1
- Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.Mira Jung, Keith Kowalczyk, Ryan Hankins, Gaurav Bandi, Bhaskar Kallakury, Michael A Carrasquilla, Partha P Banerjee, Scott Grindrod, Anatoly Dritschilo> ;Cancer Research Communications. 2022 Dec 1
- Join now to see all
Press Mentions
- Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate UpdateMay 26th, 2023
- Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation CandidatesMarch 22nd, 2023
- Shuttle Pharmaceuticals Provides Fiscal Year 2022 Corporate UpdateMarch 15th, 2023
- Join now to see all
Grant Support
- Mechanisms Of Cellular Responses To Ionizing RadiationNational Cancer Institute1997–2006
- Cancer Center Support GrantNational Cancer Institute2005
- Georgetown University AP4 Center PLANNational Cancer Institute2004
- Radiosensitization Of Pancreatic Cancers Through RAF-1National Cancer Institute2002
- Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1997–2001
- ATM Gene In Breast Cancer--Prospective Clinical TrialNational Cancer Institute1997–2001
- Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1987–2000
- Oligonucleotide Manipulation--Tumor Cell RadioresistanceNational Cancer Institute1994
- Radiation Resistance And Adp-Ribose MetabolismNational Cancer Institute1992–1994
- Molecular Basis Of Tumor Resistance To Ionize RadiationNational Cancer Institute1990–1992
- Characterization Of Differential Gene Expression In Resistant CellsNational Cancer Institute1990–1992
Professional Memberships
- Member
Hospital Affiliations
- MedStar Georgetown University HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: